S. 1634 · 117th Congress FDA Review of Efficacy of EERW Double-Blinds of Opioids Act StageIn committee SponsorJoe Manchin Introduced2021-05-13 Latest action2021-05-13 · Introduced in Senate Follow Summary Text Subjects Cosponsors (1) Votes (0) Actions Text